Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00445068 · BASELINE

Baseline characteristics

Efficacy and Safety of LBH589B in Adult Patients With Multiple Myeloma · Source last updated 2021-07-14

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      38
    units
    Participants
groups
  1. description
    Participants received panobinostat 20 mg orally OD, three times a week on days: 1, 3 and 5, then 8, 10 and 12, then 15, 17 and 19 of each cycle, as part of a 3-week (21 days) treatment cycle.
    id
    BG000
    title
    Panobinostat
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          6.58
          value
          60
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          14
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          24
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          5
      title
      Black
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          31
      title
      Caucasian
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          1
      title
      Other
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          1
      title
      Pacific islander
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race/Ethnicity, Customized
    unit Of Measure
    Participants
population Description
The analysis was performed Full Analysis Set (FAS) was defined according to the Intention to Treat (ITT) principle. This population included all participants enrolled into the study. Enrolled patients were those who had received at least one dose of study medication.
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      38
    units
    Participants
groups
  1. description
    Participants received panobinostat 20 mg orally OD, three times a week on days: 1, 3 and 5, then 8, 10 and 12, then 15, 17 and 19 of each cycle, as part of a 3-week (21 days) treatment cycle.
    id
    BG000
    title
    Panobinostat
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          6.58
          value
          60
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          14
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          24
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          5
      title
      Black
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          31
      title
      Caucasian
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          1
      title
      Other
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          1
      title
      Pacific islander
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race/Ethnicity, Customized
    unit Of Measure
    Participants
population Description
The analysis was performed Full Analysis Set (FAS) was defined according to the Intention to Treat (ITT) principle. This population included all participants enrolled into the study. Enrolled patients were those who had received at least one dose of study medication.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice